Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	297.22B -48.2%
Revenue (ttm)	845.30B +4.3%
Net Income	23.75B -8.8%
EPS	1,944.00 -8.9%
Shares Out	12.21M
PE Ratio	12.53
Forward PE	n/a
Dividend	880.00 (3.21%)
Ex-Dividend Date	May 26, 2026

Volume	38,045
Open	27,150
Previous Close	27,400
Day's Range	24,050 - 27,200
52-Week Range	22,150 - 76,700
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 20, 2026

Data Sources Report a data error